Cite

HARVARD Citation

    Mihara, Y. et al. (2019). Malic enzyme 1 is a potential marker of combined hepatocellular cholangiocarcinoma, subtype with stem‐cell features, intermediate‐cell type. Hepatology research. 49 (9), pp. 1066-1075. [Online]. 
  
Back to record